Harbor Investment Advisory’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.5K Hold
150
– – ﹤0.01% 1002
2026
Q2
$17.8K Hold
150
– – ﹤0.01% 964
2026
Q1
$15.6K Hold
150
– – ﹤0.01% 826
2025
Q4
$15.7K Hold
150
– – ﹤0.01% 860
2025
Q3
$13.9K Hold
150
– – ﹤0.01% 851
2025
Q2
$12K Hold
150
– – ﹤0.01% 859
2025
Q1
$13K Hold
150
– – ﹤0.01% 822
2024
Q4
$12.4K Hold
150
– – ﹤0.01% 825
2024
Q3
$13K Hold
150
– – ﹤0.01% 820
2024
Q2
$12.3K Hold
150
– – ﹤0.01% 816
2024
Q1
$12K Hold
150
– – ﹤0.01% 830
2023
Q4
$11.4K Hold
150
– – ﹤0.01% 816
2023
Q3
$10.9K Hold
150
– – ﹤0.01% 803
2023
Q2
$11.3K Hold
150
– – ﹤0.01% 1007
2023
Q1
$11.4K Hold
150
– – ﹤0.01% 1009
2022
Q4
$11.8K Hold
150
– – ﹤0.01% 992
2022
Q3
$11K Hold
150
– – ﹤0.01% 1028
2022
Q2
$11K Hold
150
– – ﹤0.01% 1019
2022
Q1
$12K Hold
150
– – ﹤0.01% 1033
2021
Q4
$12K Hold
150
– – ﹤0.01% 1027
2021
Q3
$12K Hold
150
– – ﹤0.01% 1032
2021
Q2
$12K Hold
150
– – ﹤0.01% 985
2021
Q1
$12K Hold
150
– – ﹤0.01% 954
2020
Q4
$11K Hold
150
– – ﹤0.01% 916
2020
Q3
$10K Hold
150
– – ﹤0.01% 854
2020
Q2
$10K Hold
150
– – ﹤0.01% 787
2020
Q1
$8K Hold
150
– – ﹤0.01% 791
2019
Q4
$10K Buy
+150
New +$9.13K ﹤0.01% 637

Other funds holding PJP

Harbor Investment Advisory's PJP Position: Q3 2026 in Review

Harbor Investment Advisory held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 150 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Harbor Investment Advisory first reported a position in PJP in Q4 2019 and has held it in 28 quarters since. 8 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Harbor Investment Advisory held 150 shares of Invesco Pharmaceuticals ETF worth $18.5K as of Q3 2026.
  • Harbor Investment Advisory left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q3 2026, its #1002 holding.
  • Harbor Investment Advisory first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 28 quarters since.
  • 8 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Harbor Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.